Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Clinical trial NCT00075868 · COMPLETED

Trial details

NCT number: NCT00075868
Sponsor: Radiation Therapy Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anal Cancer Colorectal Cancer Drug/Agent Toxicity by Tissue/Organ Radiation Enteritis

Start date: 2003-12-01
Primary completion: 2006-08-01
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.